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Summary
Objective: The long-term effect of hyaluronan (HA) on meniscus remodeling and articular cartilage preservation was assessed during the
development of osteoarthritis following partial meniscectomy in a rabbit model.
Design: Approximately 60% of the region of each medial meniscus of 20 rabbit knees was excised bilaterally. The left knee joint was treated
with five weekly intraarticular injections of 0.3 ml of HA, beginning 1 week after surgery. The right control knee was injected with PBS on the
same schedule. Six months after surgery, animals were killed and the medial menisci and tibial articular cartilage were evaluated
morphologically, histologically and biochemically.
Results: Meniscal regeneration was observed as newly synthesized translucent tissue, and image analysis revealed that the amount of this
tissue was significantly greater in the HA-treated menisci than in the vehicle-treated menisci. Safranin-O staining and image analysis
revealed the increased presence of glycosaminoglycans in the HA-treated menisci relative to vehicle-treated menisci while vascularity and
biochemical parameters (hydration, total GAGs and reducible collagen crosslinks) were statistically similar in HA- and vehicle-treated
menisci. Gross morphologic grading with India ink revealed a trend for less deterioration of tibial articular cartilage in the HA group (P=0.09)
while Mankin’s score of the HA-treated tibial articular cartilage was marginally lower than that of the vehicle group (P=0.06). Biochemical
assessments showed a trend for higher total GAGs concentration in the HA-treated articular cartilage when compared to the vehicle
treatment group (P=0.06).
Conclusion: The present study has demonstrated that following partial meniscectomy, treatment with hyaluronan can enhance meniscal
regeneration and may inhibit articular cartilage degeneration as long as six months post surgery. © 2000 OsteoArthritis Research Society
International
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Osteoarthritic changes in the tibial articular cartilage follow-
ing total or partial meniscectomy have been reported in
both human and animal studies.1–7 The clinical long-term
data have also shown that articular cartilage degeneration
cannot be avoided even if partial meniscectomy is per-
formed arthroscopically.8–10 Several human clinical11–17
and animal model7,18,19 studies have reported a meniscal
synthetic response to total or partial meniscectomy.
Such response has been referred to as meniscal regener-
ation and meniscal remodeling corresponding to total and
partial meniscectomies, respectively.20 Other studies
have reported that meniscal regeneration has a
chondroprotective effect on articular cartilage following
meniscectomy.7,11,18359Intraarticular injection of hyaluronan (HA) has been uti-
lized in many countries as a pain relief procedure for knee
osteoarthritis (OA). A protective effect of HA on articular
cartilage during the early stage of OA following total menis-
cectomy has been reported.1,4,5 We postulate that non-
surgical clinical treatments such as injection of HA are
important for the long-term preservation of the articular
cartilage and enhancement of meniscus matrix remodeling
following meniscal injury and/or partial meniscectomy. The
rationale for this treatment for OA patients is based on the
known biological effects of HA. For example, HA has been
demonstrated to stimulate synovial cells isolated from OA
joints to synthesize HA in vitro,21 to inhibit the release of
glycosaminoglycans (GAGs) from papain-treated articular
cartilage matrix,22 and to stimulate tissue inhibitor of
metalloproteinase-1 (TIMP-1) in articular chondrocytes.23
As for soft tissue healing, HA increases angiogenesis and
decreases inflammatory response in ligament healing24
and stimulates the process of wound healing in the skin.25
In a rabbit model, our laboratory has recently demonstrated
active collagen remodeling and increased expression of
type I procollagen mRNA in the HA-treated menisci up to
3 months following partial meniscectomy.26 Although, when
using an animal model, HA has been shown to clear from
the joint cavity within 20 h following intraarticular injec-
tion,27 several long-term improvements in joint pain and
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OA patients.28–32 It was also demonstrated that patients
with OA of the knee who received several intraarticular
injections of HA experienced decreased progression of the
disease 1 year later, as judged by arthroscopy, than con-
trols who received no HA injections.30 Although the basis
for this long-term effect on symptoms in some patients after
intraarticular HA injection is unknown, these reports led
us to hypothesize that HA might have a long-term chondro-
protective effect during the development of OA. Thus far,
there have been no reports assessing such long-term
effects of HA on articular cartilage during the development
of OA following partial meniscectomy.
Employing a rabbit model, the present study reports the
effects of HA treatment on the medial meniscus and on
articular cartilage 6 months after partial meniscectomy of
the medial meniscus. Evaluation of the tissues includes
gross morphology, histology and quantitative biochemical
analysis.Materials and methodscartilage exposing the underlying bone.
grade.SURGICAL MODEL AND POST-SURGICAL TREATMENT
Twenty skeletally mature New Zealand white rabbits
7–8 months old and weighing 3.5–4.0 kg were used in this
study. Each animal was anesthetized with an intramuscular
injection of ketamine (80–100 mg/kg) and xylazine
(7–10 mg/kg). Both hind limbs were shaved and disinfected
with Betadine solution and the medial menisci were par-
tially removed from both knees as follows.26 A medial
parapatellar incision and arthrotomy were performed. The
patella was dislocated laterally and the knee placed in full
flexion. In the region medial to the incision, the joint capsule
was separated from the synovial tissues and the medial
collateral ligament (MCL) was exposed. A longitudinal inci-
sion was made just anterior to the MCL to separate the
synovial tissues in front of the medial meniscus and the
femur. The synovial tissues were cut transversely, turned
over and grasped to pull out the medial meniscus. This
surgical procedure allowed the medial meniscus to be
exposed without release of the MCL. Partial medial
meniscectomy was then performed using a No. 11 surgical
blade. The inner area, approximately 60% of each medial
meniscus, was excised except in the region of the anterior
and posterior horn ligament. No bleeding was observed
on the meniscectomized surface. Great care was taken not
to injure the articular cartilage surface or the cruciate
ligaments.
Following partial meniscectomy, full range of motion of
the joint was re-established and the joint was washed with
sterile saline. The capsule was closed with 4-0 mono-
filament polypropylene sutures, and the skin was closed
with 3-0 nylon sutures. After surgery, the rabbits were
returned to cage activity (60×60×40 cm). The rabbits were
given intramuscular injection of analgesics (buprenorphine
HCl 0.01–0.02 mg/kg) for 3 days and antibiotics (enro-
floxacin 1.0–1.3 mg/kg) for 7 days after surgery.
Beginning 1 week after surgery, the left knee joints
received intraarticular injections of 0.3 ml of hyaluronate
(MW=8×105 Daltons; Seikagaku Corp., Tokyo, Japan)33
once a week for 5 weeks, in a protocol similar to that used
clinically.29,31,32 The right knees were injected with a
vehicle (carrier of HA: phosphate buffered saline). During
intraarticular injection the animals were anesthetized intra-
muscularly with small doses of ketamine and xylazine. Allrabbits were killed at 6 months post-surgery with an intra-
cardiac injection of a mixed solution of pentobarbital
sodium, phenytoin sodium, ethyl alcohol and propylene
glycol. Immediately after death the medial menisci and
tibial articular cartilage from HA and vehicle treated knees
were dissected and randomly designated for the following
assessments.QUANTITATIVE MORPHOLOGIC ASSESSMENT
Quantitative morphologic analysis of the medial menisci
(N=6) and tibial articular cartilage (N=8) was evaluated as
described previously.26 Photographs of the menisci were
scanned and total meniscal area and area of new growth
were calculated by image analysis using NIH Image 1.60
software, National Institutes of Health, USA. To evaluate
articular cartilage damage the medial tibial plateaus were
brushed with India ink and examined for signs of erosion
and/or fibrillation. The examination was performed blindly
by two observers and averaged to minimize the effects of
observer bias. Changes in the articular cartilage were
graded as follows: Grade 1 (intact surface)—surface nor-
mal in appearance and did not retain ink; grade 2 (minimal
fibrillation)—site appeared normal before staining, but the
India ink showed fibrillation; grade 3 (overt erosion)—
areas were apparent before staining and retained ink
as intense black patches; grade 4 (ulceration)—loss of
33–36HISTOLOGICAL ASSESSMENT
Menisci (N=4) and articular cartilage (N=6) were fixed in
10% buffered formalin with 1% cetylpyridinium chloride
(CPC) and embedded in paraffin. The articular cartilage
together with bone tissue was decalcified in ethylene-
diamine tetraacetic acid (EDTA) before embedding. Six
micrometre-thick sagittal sections were cut and stained
with hematoxylin and eosin (H&E) for cellular detail and
safranin-O/fast green for the presence of GAGs. The speci-
mens were evaluated by light microscopy. Mean density of
safranin-O stained area in menisci was determined using
NIH image analysis (1.60) software while histological
changes in the articular cartilage of the medial tibial plateau
were evaluated according to the Mankin’s grading system:
histological sections stained with safranin-O/fast green,
were analysed for abnormalities in structure, cell popu-
lation, safranin-O stain (GAGs) distribution, and tidemark
integrity. Scores were given a histologic-histochemical
37VASCULAR ASSESSMENT OF MEDIAL MENISCI
Animals (N=4) were anesthetized with intramuscular
ketamine and xylazine. Each abdominal descending aorta
was exposed and cannulated with a polyethylene catheter.
One hundred and fifty milliliters of filtered India ink was
perfused into the aorta with continuous manual pressure
and the animals killed. Modified Spalteholz technique was
used for tissue clearing. The menisci were fixed in 10%
buffered formalin with 1% CPC for 3 days and washed in
running water for 8 h. After dehydration by passing through
changes of 70% to 100% ethanol, specimens were
immersed in methyl salicylate until tissue clearing was
advanced. Sagittal sections with 1–2 mm thickness were
investigated under light microscopy.
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Biochemical characterization of whole medial menisci
(N=6) included quantitative measurements of water con-
tent, total GAGs, and the reducible collagen cross-link,
dihydroxylysinonorleucine (DHLNL). Articular cartilage
(N=6) was dissected as completely as possible from the
tibial plateau for determination of water content and total
GAGs.
Hydration: Hydration levels in menisci and cartilage were
determined by measuring wet and dry weights in these
tissues and calculating percentage water content.
Total glycosaminoglycans: Total GAGs concentration
was determined in menisci and tibial plateau cartilage by
measuring the concentrations of hexosamine contained in
the tissues. Two to four milligrams of dry tissue were
hydrolysed in 6 N HCl at 100°C for 5 h. The amount
of hexosamine was then calculated as previously
described.38 Results are expressed as micrograms hex-
osamine per mg of dry tissue.
Reducible collagen cross-links: The reducible collagen
cross-link DHLNL was quantified in medial menisci in order
to assess collagen remodeling in this tissue. Samples of
lyophilized tissue were reduced with tritium-labeled sodium
borohydride and then hydrolysed in 6 N HCl. Isolation of the
cross-link was accomplished by cation-exchange HPLC
and quantitation was achieved with in-line liquid scintillation
spectrometry.26 Results are expressed as counts per
minute (cpm) per picomole of total collagen.STATISTICAL ANALYSIS
Quantitative data were presented in the text as
mean±standard deviation of the mean. For comparisons of
quantitative measures between the vehicle- and the
HA-group, the values were subjected to statistical analysis
using paired Student’s t-test. A modified arcsine transfor-
mation was applied to proportional data as a variance
stabilizing measure. For the semi-quantitative scales of
morphologic and histologic changes, the scores were
ranked and between-group differences were tested using
the Mann–Whitney U test.ResultsFig. 1. Meniscal remodeling 6 months after partial meniscectomy and treatment with either vehicle or hyaluronan. (a) Gross appearance of
a representative specimen from each treatment group. Note the areas of new growth (arrows). (b) Image analysis quantitation of areas of
new growth. Results are shown as mean±standard deviation. Note that the percentage of new growth was statistically higher in the
HA-treated specimens than in the vehicle-treated specimens.MENISCUS
Gross assessment of the medial menisci at 6 months
following partial meniscectomy revealed the presence of
newly deposited translucent tissue in both vehicle-treated
and HA-treated specimens [Fig. 1(a)]. However, image
analysis revealed that the mean of the percentage new
tissue area [translucent tissue area/total area of medial
meniscus) in the HA-treated medial menisci was signifi-
cantly (P<0.05) higher than in the vehicle-treated menisci:
19.2±4.0% vs 13.9±3.8%, respectively; Fig. 1(b)].
Histological evaluation (safranin-O staining) revealed
localized staining of GAGs in the region of new tissue
growth [Fig. 2(a)]. Image analysis demonstrated that such
localized staining was present at an increased (P<0.05)
362 K. Kobayashi et al.: Long-term effects of hyaluronanlevel in the HA-menisci relative to the vehicle-treated
menisci [Fig. 2(b)]. India ink injection studies demonstrated
a similar vascular network in HA-treated and vehicle-
treated menisci. Quantitative biochemical analysis of
menisci from vehicle- and HA-treated knees demonstrated
no statistically significant differences in water content, total
GAGs or DHLNL.Fig. 2. Histological assessment of medial menisci six months after partial meniscectomy and treatment with either vehicle or hyaluronan.
(a) Safranin-O stained areas in areas of new growth. (b) Image analysis quantitation of safranin-O stained areas; results expressed as
mean±standard deviation. Note that HA-treated menisci had greater safranin-O staining than did vehicle-treated menisci.Fig. 3. Gross appearance of a representative specimen of tibial articular cartilage at 6 months following partial meniscectomy and treatment
with either vehicle or hyaluronan. Note that damage to the cartilage surface appeared to be more severe (grade 3) in the vehicle-treated
specimens than in the HA-treated specimens (grade 2).ARTICULAR CARTILAGE
Figure 3 shows representative specimens of tibial
plateau from vehicle-treated and HA-treated joints followingpartial meniscectomy. Morphological grading with India
ink revealed that two vehicle-injected knees and no
HA-injected knees exhibited grade 3 pittings into the carti-
lage surface on the posteromedial aspect of the tibial
plateau. Minor fibrillation of the medial tibial articular carti-
lage (grade 2) was observed in five vehicle-injected rabbits
and four HA-injected rabbits (Table I). A trend for an overall
lower grading (P=0.09) was seen in the HA group than in
the vehicle group. Gross examination revealed no detect-
able osteoarthritic changes in the femoral condyles in either
group 6 months after partial meniscectomy. Histological
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lated cartilage surfaces and vertical clefts reaching into the
radial zone in two of four vehicle-treated tibial plateau
specimens and no HA-treated specimens (Fig. 4). Minor
changes in the intensity of safranin-O staining of HA-
treated cartilage were observed, but the tide marks were
preserved with normal appearance in all samples from the
HA-treatment group. Mankin’s grading system37 showed
that the average value in the vehicle-treated tibial cartilage
had a trend for a higher score compared to the HA-treated
cartilage (P=0.06).
Biochemical analysis of the articular cartilage from the
tibial plateau demonstrated no statistically significant differ-
ences in water content between vehicle-treated and
HA-treated knees. However, the HA-treated tibial cartilage
showed a marginally higher amount of total GAGs than
vehicle-treated cartilage (P=0.06; Fig. 5).Table I
Distribution of morphologic grading of the articular cartilage of
eight medial tibial plateaus 6 months after partial meniscectomy
OA grade Vehicle–treated
cartilage
HA–treated
cartilage
I 1 4
II 5 4
III 2 0
IV 0 0Fig. 4. Histological assessment (safranin-O/fast green) of a grade 3 vehicle-treated specimen of tibial articular cartilage at 6 months after
partial meniscectomy and a grade 2 HA-treated specimen. Note the extensive fibrillation of articular surface and vertical clefts extending into
the radial zone (arrow) in the vehicle treated specimen; the HA-treated cartilage, by contrast, contained a more intact surface and exhibited
a more normal tide mark region (arrow).Discussion
The results of the present study supports the hypothesis
that intraarticular injections of HA enhances meniscal
remodeling and provides some long-term (6 months) chon-
droprotection during the development of OA following par-tial meniscectomy. In a previous study,26 using the same
model, newly synthesized translucent tissue in medial
menisci was observed 3 months post-surgery, but we were
unable to detect a statistical difference for the amount of
this tissue between vehicle- and HA-injected knees. How-
ever, active collagen remodeling at 3 months was demon-
strated biochemically, i.e. increased DHLNL concentration
and increased expression of type I procollagen mRNA, in
the HA-treated menisci when compared to the vehicle-
treated menisci. These observations indicated that HA had
the ability to enhance meniscal remodeling. In the current
study, examination at 6 months post-surgery showed no
difference for DHLNL concentration in the medial menisci
between vehicle- and HA-treatments. Thus, it was specu-
lated that the effect of HA mentioned above, had reached a
steady state by 6 months following partial meniscectomy.
As a consequence of increased collagen remodeling at 3
months, a significantly larger area of regenerated tissue in
the HA-treated medial menisci, compared to vehicle-
treated menisci, was seen at 6 months. Although we were
unable to detect a significant difference biochemically for
the amount of GAGs in the whole menisci between vehicle-
and HA-treated knees, a stronger local safranin-O staining
of GAGs in the regenerated tissue of HA-treated meniscus
was observed. HA-enhanced meniscal remodeling might
provide one of the positive effects of HA for the preser-
vation of articular cartilage following partial meniscectomy,
since meniscal regeneration was reported to have a pro-
tective role on articular cartilage after meniscectomy.7,11,18
In a previous study we demonstrated no significant
differences between the vehicle- and HA-treated cartilage
morphologically or biochemically in a 3 month short-term
study.26 However, in the present 6 month study we have
shown a trend toward higher amounts of total GAGs
(P=0.06) and less morphological degradation (P=0.09)
in the HA-treated medial tibial articular cartilage than in
364 K. Kobayashi et al.: Long-term effects of hyaluronanvehicle-treated cartilage. These data suggest that a
chondroprotective effect of HA was maintained between
three and six months post surgery, even though HA was
long cleared from the joint cavity by that time.
As for the basis of the long-term effects of HA, we
postulate that intraarticularly injected HA diffuses in the
synovial fluid and is incorporated into the synovial tissues.
Other studies have shown that during the initial stages after
injection of exogenous HA, HA in the synovial fluid
decreases in molecular weight, and in later stages, the
molecular weight of HA in the synovial fluid increases to a
value greater than the original before the injection.39 This
phenomenon has been explained by the theory that
exogenous HA stimulates the production of endogenous
HA by positive feedback.40 In a positive feedback mech-
anism, exogenous HA may induce synovial cells (type B) to
synthesize endogenous HA of higher molecular weight.21 It
has been shown that intrinsic HA is important for cell
movement24,25 and the regulation of extracellular matrix
aggregation and synthesis.22,41 These previous findings
and our present results, collectively, suggest that a similar
mechanism may underlie the long-term chondroprotective
effect of HA following partial meniscectomy; there is the
possibility that extrinsic HA incorporated into synovial tis-
sues may activate the production of the intrinsic HA, which
may have been up-regulated in long periods by the positive
feedback mechanism. An increase in cartilage GAG con-
tent would result in a decrease in the hydraulic permeability
of the cartilage and an increase in its stiffness on compres-
sion.42 In conclusion, the present study has supported one
of the rationales for HA treatment following partial menis-
cectomy although the exact mechanism of long-term
effects of HA during development of OA remains to be
determined.Fig. 5. Quantitative biochemical characterization of tibial articular cartilage from vehicle and HA-treated knees at 6 months following partial
meniscectomy. (a) Water content of cartilage; (b) total GAGs content as measured by hexosamine concentration. Results are expressed as
mean±standard deviation.References
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